Steady-state Kinetics and Inhibitory Action of Antitubercular Phenothiazines on Mycobacterium tuberculosis Type-II NADH-Menaquinone Oxidoreductase (NDH-2)
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Type-II NADH-menaquinone oxidoreductase (NDH-2) is an essential respiratory enzyme of the pathogenic bacterium Mycobacterium tuberculosis (Mtb) that plays a pivotal role in its growth. In the present study, we expressed and purified highly active Mtb NDH-2 using a Mycobacterium smegmatis expression system, and the steady-state kinetics and inhibitory actions of phenothiazines were characterized. Purified NDH-2 contains a non-covalently bound flavin adenine dinucleotide cofactor and oxidizes NADH with quinones but does not react with either NADPH or oxygen. Ubiquinone-2 (Q2) and decylubiquinone showed high electron-accepting activity, and the steady-state kinetics and the NADH-Q2 oxidoreductase reaction were found to operate by a ping-pong reaction mechanism. Phenothiazine analogues, trifluoperazine, Compound 1, and Compound 2 inhibit the NADH-Q2 reductase activity with IC50 = 12, 11, and 13 microm, respectively. Trifluoperazine inhibition is non-competitive for NADH, whereas the inhibition kinetics is found to be uncompetitive in terms of Q2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![FIGURE 5 Hanes plots of the steady-state kinetics of the NADH-Q2 oxidoreductase activity of the purified Mtb NDH-2. Q2 reductase activities at various Q2 concentrations were plotted in a Hanes-Woolf plot ([Q2] versus [Q2]/ v ) and a Lineweaver-Burk plot (1/[Q2] versus 1/ v , inset ). NADH concentrations were varied: 10 𝛍 M ( closed square ), 20 𝛍 M ( open triangle ), 30 𝛍 M ( closed triangle ), 50 𝛍 M ( open circle ), and 100 𝛍 M ( closed circle ).](https://figures.cochat.ai/paper-figures/b925cfb0107748a485452f1156db312d/steady-state-kinetics-and-inhibitory-action-of-antitubercular-phenothiazines-on-figure-5.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NDH-2 has not been reported in mammalian mitochondria leading to the proposal that these enzymes may represent a potential drug target for the treatment of human pathogens (6, 12, 27, 30, 31) and intracellular parasites (32).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Messner, K. R., & Imlay, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10119 · Cited by 299
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
Self-citationA rapid micromethod for determination of FMN and FAD in mixtures
Faeder, E. J., & Siegel, L. M. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90442-9 · Cited by 288
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
New Insights into Type II NAD(P)H:Quinone Oxidoreductases
Melo, A. M. P., Bandeiras, T. M., & Teixeira, M. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.603-616.2004 · Cited by 270
Ordway, D., Viveiros, M., Leandro, C., Bettencourt, R., Almeida, J., Martins, M., Kristiansen, J. E., Molnar, J., & Amaral, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.917-922.2003 · Cited by 200
de VRIES, S., & GRIVELL, L. A. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14292.x · Cited by 195
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Collins, M. D., Shah, H. N., & Minnikin, D. E. (1980) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1980.tb01227.x · Cited by 154
Amaral, L., Kristiansen, J. E., Abebe, L. S., & Millett, W. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.6.1049 · Cited by 138
Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections
Crowle, A. J., Douvas, G. S., & May, M. H. (2009) · Chemotherapy · doi:10.1159/000239036 · Cited by 128
McAdam, R. A., Quan, S., Smith, D. A., Bardarov, S., Betts, J. C., Cook, F. C., Hooker, E. U., Lewis, A. P., Woollard, P., Everett, M. J., et al. (2002) · Microbiology · doi:10.1099/00221287-148-10-2975 · Cited by 128
Fang, J. S., & Beattie, D. S. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01328-x · Cited by 109
Björklöf, K., Zickermann, V., & Finel, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01130-3 · Cited by 68
Eschemann, A., Galkin, A. S., Oettmeier, W., Brandt, U., & Kerscher, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411217200 · Cited by 67
Mitochondrial ATP synthase complex. Membrane topography and stoichiometry of the F0 subunits
Hekman, C., Tomich, J. M., & Hatefi, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92736-5 · Cited by 65
Purification and Characterization of NADH Dehydrogenase from Bacillus subtilis
Bergsma, J., van Dongen, M. B. M., & Konings, W. N. (2005) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06945.x · Cited by 64
Cook, S. A., & Shiemke, A. K. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2628 · Cited by 55
Velázquez‐López, I., & Pardo, J. P. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2293 · Cited by 54
Nantapong, N., Otofuji, A., Migita, C. T., Adachi, O., Toyama, H., & Matsushita, K. (2005) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.69.149 · Cited by 51
Matsushita, K., Otofuji, A., Iwahashi, M., Toyama, H., & Adachi, O. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10896.x · Cited by 42
Antitubercular activity of trifluoperazine, a calmodulin antagonist
Ratnakar, P., & Murthy, P. S. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05442.x · Cited by 39
Bandeiras, T. M., Salgueiro, C. A., Kletzin, A., Gomes, C. M., & Teixeira, M. S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03514-7 · Cited by 33
Nantapong, N., Kugimiya, Y., Toyama, H., Adachi, O., & Matsushita, K. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1659-6 · Cited by 31
Bandeiras, T. M., Salgueiro, C. A., Huber, H., Gomes, C. M., & Teixeira, M. S. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(02)00374-2 · Cited by 28
Heltzel, A., Smith, E. T., Zhou, Z. H., Blamey, J. M., & Adams, M. W. W. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.15.4790-4793.1994 · Cited by 28
Gadre, D. V., Talwar, V., Gupta, H. C., & Murthy, R. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00006 · Cited by 25
Conjugal transfer of cloning vectors derived from ColE1
Young, I. G., & Poulis, M. I. (1978) · Gene · doi:10.1016/0378-1119(78)90029-x · Cited by 23
In-vitro and intracellular antimycobacterial activity of trifluoperazine
REDDY, M. V., Nadadhur, G., & Gangadharam, P. R. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.196 · Cited by 20
Gomes, C. M., & Teixeira, M. S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8111 · Cited by 20
Effect of trifluoperazine on in vitro ATP synthesis by Mycobacterium leprae
Katoch, V. M., Saxena, N., Shivannavar, C. T., Sharma, V. D., Katoch, K., Sharma, R., & Murthy, P. S. (1998) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1998.tb01115.x · Cited by 15
Research works printed but not linked: 2
- Molnar, 1977, Zentralbl Bakteriol [Orig. A], 239, 521
- Kristiansen, 1986, Acta Pathol. Microbiol. Immunol. Scand. B, 94, 393
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
“Although there are currently no drugs approved for TB treatment that target mycobacterial NDH2, experimental observations with the NDH2 inhibitors phenothiazines, chlorpromazine and thioridazine (which are antipsychotic drugs) provide a case for targeting NDH2 (Ref”
Mycobacterium tuberculosis: success through dormancy
Gengenbacher, M., & Kaufmann, S. H. E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00331.x · Cited by 696
“…Mtb remains sensitive to inhibition of NADH dehydrogenase 2, a single protein enzyme that can serve as alternate entry point of electrons into the electron transport chain but lacks proton translocation capacity (Xie et al., 2005; Yano et al., 2006; Teh et al., 2007; Gengenbacher et al., 2010).”
BackgroundRao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517
Alvin, A., Miller, K. I., & Neilan, B. A. (2014) · Microbiological Research · doi:10.1016/j.micres.2013.12.009 · Cited by 373
Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
Yano, T., Kassovska-Bratinova, S., Teh, J. S., Winkler, J., Sullivan, K., Isaacs, A., Schechter, N. M., & Rubin, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200501 · Cited by 346
Self-citation
Metadata
- Authors
- Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Rubin, Harvey
- ORCID
- Rubin, Harvey
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 281
- Issue
- 17
- Pages
- 11456-11463
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040519812
- Cited by
- 150
- References
- 38
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 10 · 2015: 6 · 2014: 16 · 2013: 4 · 2012: 11
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5296 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI043420, AI-43420)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Mycobacterium tuberculosis, NDH-2, phenothiazines, antitubercular agents, enzyme inhibition kinetics, ping-pong mechanism, trifluoperazine, non-competitive inhibition
- MeSH terms
- Antitubercular Agents, Binding, Competitive, Enzyme Inhibitors, Flavin-Adenine Dinucleotide, Kinetics, Mycobacterium tuberculosis, NAD, Phenothiazines, Quinone Reductases, Quinones, Ubiquinone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.